These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34655050)

  • 41. Differential effects of C-reactive protein levels on voriconazole metabolism at three age groups in allogeneic hematopoietic cell transplant recipients.
    Luo X; Li T; Hu L; Liu S; Zhao H; Zhang J; Feng Y; Huang L
    J Chemother; 2021 Apr; 33(2):95-105. PubMed ID: 32441568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of letermovir on levonorgestrel and ethinyl estradiol pharmacokinetics
.
    Adedoyin A; Cho CR; Fox-Bosetti S; Macha S; Zhao T; Liu F; Panebianco D; O'Reilly TE; McCrea J; Stoch SA; Iwamoto M
    Int J Clin Pharmacol Ther; 2019 Sep; 57(9):450-457. PubMed ID: 31232280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experience.
    Lin A; Maloy M; Su Y; Bhatt V; DeRespiris L; Griffin M; Lau C; Proli A; Barker J; Shaffer B; Giralt SA; Jakubowski AA; Papadopoulos EB; Papanicolaou GA; Seo SK; Perales MA
    Transpl Infect Dis; 2019 Dec; 21(6):e13187. PubMed ID: 31585500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sirolimus pharmacokinetics in early postmyeloablative pediatric blood and marrow transplantation.
    Goyal RK; Han K; Wall DA; Pulsipher MA; Bunin N; Grupp SA; Mada SR; Venkataramanan R
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):569-75. PubMed ID: 23266742
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The Application Study of Voriconazole and Its Metabolites Concentration Monitoring in Allogeneic Hematopoietic Stem Cell Transplantation Patients].
    Wang HC; Wang L; Li M; Shi L; Sun HH; Liu HX; Ou HL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):945-951. PubMed ID: 38926993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Highly variable plasma concentrations of voriconazole in pediatric hematopoietic stem cell transplantation patients.
    Bartelink IH; Wolfs T; Jonker M; de Waal M; Egberts TC; Ververs TT; Boelens JJ; Bierings M
    Antimicrob Agents Chemother; 2013 Jan; 57(1):235-40. PubMed ID: 23114771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence of CMV Replication and the Role of Letermovir Primary/Secondary Prophylaxis in the Early Phase After Allogeneic Hematopoietic Stem Cell Transplantation - A Single Centre Study.
    Studer U; Khanna N; Leuzinger K; Hirsch HH; Heim D; Lengerke C; Tsakiris DA; Halter J; Gerull S; Passweg J; Medinger M; Gwerder M
    Anticancer Res; 2020 Oct; 40(10):5909-5917. PubMed ID: 32988922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
    Marty FM; Lowry CM; Cutler CS; Campbell BJ; Fiumara K; Baden LR; Antin JH
    Biol Blood Marrow Transplant; 2006 May; 12(5):552-9. PubMed ID: 16635790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Model-Oriented Dose Optimization of Voriconazole in Critically Ill Children.
    Wang J; Xu H; Li R; Wu S; Zou J; Wang Y
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0049321. PubMed ID: 34152812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients.
    Trifilio S; Pennick G; Pi J; Zook J; Golf M; Kaniecki K; Singhal S; Williams S; Winter J; Tallman M; Gordon L; Frankfurt O; Evens A; Mehta J
    Cancer; 2007 Apr; 109(8):1532-5. PubMed ID: 17351937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multicenter-Based Population Pharmacokinetic Analysis of Ciclosporin in Hematopoietic Stem Cell Transplantation Patients.
    Xue L; Zhang WJ; Tian JX; Liu LN; Yan HH; Zhang WW; Ding XL; Zhang JJ; Miao LY
    Pharm Res; 2019 Dec; 37(1):15. PubMed ID: 31873806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of long-term and short-term administration of itraconazole for primary antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: a multicenter, randomized, open-label trial.
    Lin R; Xu X; Li Y; Sun J; Fan Z; Jiang Q; Huang F; Zhou H; Nie D; Guo Z; Mao Y; Xiao Y; Liu Q
    Transpl Infect Dis; 2014 Apr; 16(2):286-94. PubMed ID: 24593273
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patients.
    Xue L; Zhang WW; Ding XL; Zhang JJ; Bao JA; Miao LY
    Am J Med Sci; 2014 Dec; 348(6):448-54. PubMed ID: 25247760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Rosillo C; Avila AM; Huang YT; Devlin S; Cho C; Montoro J; Maloy MA; Papanicolaou GA; Barba P; Perales MA
    Transpl Infect Dis; 2018 Aug; 20(4):e12897. PubMed ID: 29668073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Converting cyclosporine A from intravenous to oral administration in hematopoietic stem cell transplant recipients and the role of azole antifungals.
    Atiq F; Hameli E; Broers AEC; Doorduijn JK; Van Gelder T; Andrews LM; Koch BCP; Versmissen J; de Winter BCM
    Eur J Clin Pharmacol; 2018 Jun; 74(6):767-773. PubMed ID: 29500599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genotype-Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation.
    Teusink A; Vinks A; Zhang K; Davies S; Fukuda T; Lane A; Nortman S; Kissell D; Dell S; Filipovich A; Mehta P
    Biol Blood Marrow Transplant; 2016 Mar; 22(3):482-6. PubMed ID: 26616742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug interaction between voriconazole and tacrolimus and its association with the bioavailability of oral voriconazole in recipients of allogeneic hematopoietic stem cell transplantation.
    Mori T; Kato J; Yamane A; Sakurai M; Kohashi S; Kikuchi T; Ono Y; Okamoto S
    Int J Hematol; 2012 May; 95(5):564-9. PubMed ID: 22461034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Letermovir for the prevention of cytomegalovirus infection in adult cytomegalovirus-seropositive hematopoietic stem cell transplant recipients.
    Foolad F; Aitken SL; Chemaly RF
    Expert Rev Clin Pharmacol; 2018 Oct; 11(10):931-941. PubMed ID: 30004790
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Application of different pharmacokinetic models to describe and predict pharmacokinetics of voriconazole in magellanic penguins following oral administration.
    Parsley RA; Mutlow AG; Hansted J; Taverne FJ; Tell LA; Gehring R
    J Vet Pharmacol Ther; 2019 Jan; 42(1):74-84. PubMed ID: 30175535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PBPK Modeling Strategy for Predicting Complex Drug Interactions of Letermovir as a Perpetrator in Support of Product Labeling.
    Wang YH; Chen D; Hartmann G; Cho CR; Menzel K
    Clin Pharmacol Ther; 2019 Feb; 105(2):515-523. PubMed ID: 29901213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.